Cycloleucine
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cycloleucine
Description :
Cycloleucine is a specific inhibitor of S-adenosyl-methionine mediated methylation. Cycloleucine is antagonist of NMDA receptor associated glycine receptor, with a Ki of 600 μM. Cycloleucine is also a competitive inhibitor of ATP: L-methionine-S-adenosyl transferase in vitro. Cycloleucine has anxiolytic and cytostatic effects[1][2][3][4].UNSPSC :
12352211Hazard Statement :
H301Target :
IGluRType :
Reference compoundRelated Pathways :
Membrane Transporter/Ion Channel; Neuronal SignalingApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Cancer; Infection; Metabolic Disease; Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/cycloleucine.htmlPurity :
98.0Solubility :
DMSO : < 1 mg/mL (ultrasonic) |H2O : 20 mg/mL (ultrasonic)Smiles :
O=C(O)C1(CCCC1)NMolecular Formula :
C6H11NO2Molecular Weight :
129.16Precautions :
H301References & Citations :
[1]Hood WF, et, al. 1-Aminocyclobutane-1-carboxylate (ACBC) : a specific antagonist of the N-methyl-D-aspartate receptor coupled glycine receptor. Eur J Pharmacol. 1989 Feb 28;161 (2-3) :281-2.|[2]Caboche M, et, al. RNA methylation and control of eukaryotic RNA biosynthesis. Effects of cycloleucine, a specific inhibitor of methylation, on ribosomal RNA maturation. Eur J Biochem. 1977 Mar 15;74 (1) :19-29.|[3]Gargiulo API, et, al. Effects of Cycloleucine in the Nucleus Accumbens Septi on the Elevated plus Maze Test in Rats. Neuropsychobiology. 2020;79 (3) :191-197.|[4]Dimock K, et, al. Cycloleucine blocks 5'-terminal and internal methylations of avian sarcoma virus genome RNA. Biochemistry. 1978 Aug 22;17 (17) :3627-32.|[5]DuÅ› D, et, al. Cytostatic activity in vitro of cycloleucine, aspartic acid and glutamic acid phosphonic analogues. Arch Immunol Ther Exp (Warsz) . 1980;28 (3) :433-8.|[6]S Amor, et al. The effect of cycloleucine on SFV A7 (74) infection in mice. Br J Exp Pathol. 1987 Apr;68 (2) :225-35.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedIsoform :
NMDA ReceptorCAS Number :
[52-52-8]

